![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 471/04 | |
A61K 31/519 | |||
A61P 35/00 |
(11) | Number of the document | 2303875 |
(13) | Kind of document | T |
(96) | European patent application number | 09766158.1 |
Date of filing the European patent application | 2009-06-18 | |
(97) | Date of publication of the European application | 2011-04-06 |
(45) | Date of publication and mention of the grant of the patent | 2012-11-28 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2009/050695 |
Date | 2009-06-18 |
(87) | Number | WO 2009/153597 |
Date | 2009-12-23 |
(30) | Number | Date | Country code |
74188 | 2008-06-20 | US | |
152350 | 2009-02-13 | US |
(72) |
BLADE, Helen, GB
CHURCHILL, Gwydion, Huw, GB
CURRIE, Angela, Charlotte, GB
DOBSON, Benjamin, Charles, GB
HYNES, Peter, Samuel, GB
KENWORTHY, Martin, Neal, GB
POWELL, Lyn, GB
RAW, Steven, Anthony, GB
|
(73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
(54) | COMPOSITIONS WITH AND PROCESS FOR METHYLMORPHOLIN-SUBSITUTED PYRIDO[2,3-D]PYRIMIDINES |
COMPOSITIONS WITH AND PROCESS FOR METHYLMORPHOLIN-SUBSITUTED PYRIDO[2,3-D]PYRIMIDINES |